Eps8-derived peptide 327 – 1mg

Overview

The Eps8-derived peptide 327 is a highly specific 1 mg peptide designed for research and diagnostic applications. Derived from the Eps8 protein, this peptide represents a human leukocyte antigen (HLA)-A*2402-restricted epitope. Notably, it has been demonstrated to interfere with epidermal growth factor receptor (EGFR) signaling, disrupting the Eps8/EGFR complex. This makes it a crucial tool for researchers studying cancer cell viability and gene expression regulation. The Eps8-derived peptide 327 is now available for sale, ready to enhance your research insights.

Key Features

• High purity and quality
• 1 mg of peptide per vial
• Disrupts Eps8/EGFR complex formation
• Supports cancer research and gene expression studies
• Conveniently packaged for ease of use

Specifications

FAQ

What applications can the Eps8-derived peptide 327 be used for?

This peptide is primarily used in research focused on cancer and cellular signaling pathways, especially regarding the modulation of EGFR activity.

How should I store the Eps8-derived peptide 327?

For optimal stability, store the peptide at -20°C and keep it protected from moisture.

Can this peptide be used in live cell applications?

Yes, the Eps8-derived peptide 327 can be utilized in live cell experiments to study its effects on cell signaling and viability.

Enhance your research with the Eps8-derived peptide 327, available now at competitive pricing. Explore our peptide catalog for other high-quality options, including PKG Substrate and Autocamtide-2. Make a purchase today and take the next step in your research journey.

Related Products

• CREBtide [KRREILSRRPSYR], 5-FAM labeled